How have TMED shares performed in 2024?

Trimedyne's stock was trading at $4.25 at the beginning of the year. Since then, TMED stock has increased by 0.0% and is now trading at $4.25. View the best growth stocks for 2024 here .

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) released its quarterly earnings data on Tuesday, February, 20th. The technology company reported $0.70 earnings per share (EPS) for the quarter. The technology company earned $1.53 million during the quarter.

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL) , Diana Shipping (DSX) , Cohen & Steers Closed-End Opportunity Fund (FOF) , Incyte (INCY) , National Fuel Gas (NFG) , PDC Energy (PDCE) , The Rank Group (RNK) , Safehold (SAFE) , Snap (SNAP) and Aramark (ARMK) .

How do I buy shares of Trimedyne?

Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:TMED

Trimedyne (TMED) Stock Price, News & Analysis

→ A new way to collect income from stocks (From DTI) (Ad)

Free TMED Stock Alerts

$4.25

-0.01 (-0.23%)

(As of 03/20/2020)

Compare

Today's Range: $4.25
▼
$4.25
50-Day Range: $4.25
▼
$4.25
52-Week Range: $3.48
▼
$7.00

Volume: 100 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Trimedyne alerts:

Ad Priority Gold

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

About Trimedyne Stock (OTCMKTS:TMED)

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

TMED Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TMED Stock News Headlines

April 17, 2024 | americanbankingnews.com

Trimedyne (OTCMKTS:TMED) Shares Pass Below Two Hundred Day Moving Average of $4.25

April 9, 2024 | americanbankingnews.com

Trimedyne (OTCMKTS:TMED) Shares Cross Above 50 Day Moving Average of $4.25

See More Headlines

Receive TMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/20/2018
Today: 4/17/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Computer and Technology
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: OTCMKTS:TMED
CUSIP: N/A
CIK: 357001
Web: www.trimedyne.com
Phone: 949-951-3800
Fax: 949-855-8206
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Glenn D. Yeik (Age 51)
Interim Chairman, CEO & Pres
Mr. Brian T. Kenney (Age 62)
VP of Global Sales & Marketing

Key Competitors

View All Competitors

TMED Stock Analysis - Frequently Asked Questions

How have TMED shares performed in 2024?: Trimedyne's stock was trading at $4.25 at the beginning of the year. Since then, TMED stock has increased by 0.0% and is now trading at $4.25.
View the best growth stocks for 2024 here.
How were Trimedyne's earnings last quarter?: Trimedyne, Inc. (OTCMKTS:TMED) released its quarterly earnings data on Tuesday, February, 20th. The technology company reported $0.70 earnings per share (EPS) for the quarter. The technology company earned $1.53 million during the quarter.
What other stocks do shareholders of Trimedyne own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL), Diana Shipping (DSX), Cohen & Steers Closed-End Opportunity Fund (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), The Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK).
How do I buy shares of Trimedyne?: Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TMED) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial